Coeptis Therapeutics Holdings, Inc.
COEP
Transaktioner
64
Köp
62
Sälj
2
Nettoinsynsflöde
3.3 mn USD
Köpvärde minus säljvärde
Rapportanalys
Senast rapporterade siffror, automatiskt granskadeLäser senaste rapporten…
Aktiekurs och insynstransaktioner
Ingen prisdata ännuIngen prisserie har matchats mot detta bolag ännu.
Avkastning efter transaktion
Median-% efter transaktionsdatumKursserien för detta bolag rör sig i tick som är stora i förhållande till aktiekursen, så procentuell avkastning skulle domineras av avrundningsbrus snarare än av verkliga kursrörelser. Avkastningsstatistik visas därför inte.
Signalkorrelation
Månatligt nettoinsynsflöde vs avkastning–
Pearsonkorrelation mellan den signerade logaritmen av månatligt nettoinsynsköp och den månadens aktiekursavkastning, över 0 månader med aktivitet. Värden nära noll innebär att insynsflödet inte gav någon timinginformation för detta bolag.
Alla rapporterade transaktioner
64 rader| Datum | Person | Position | Typ | Volym | Pris | Värde |
|---|---|---|---|---|---|---|
| 2026-02-11 | Calise Chris | Director | Buy | 6 k | 10,56 | 60 k USD |
| 2026-02-11 | Calise Chris | Director | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-11 | Cochran Christopher P. | Director | Buy | 6 k | 10,56 | 60 k USD |
| 2026-02-11 | Cochran Christopher P. | Director | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-11 | Sheehy Christine Elise | VP Compliance and Secy | Buy | 1 k | 10,56 | 11 k USD |
| 2026-02-11 | Sheehy Christine Elise | VP Compliance and Secy | Buy | 13 k | 0,00 | 0 USD |
| 2026-02-11 | Salkind Gene | Director | Buy | 6 k | 10,56 | 60 k USD |
| 2026-02-11 | Salkind Gene | Director | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-11 | Cochran Christopher P. | Director | Buy | 6 k | 10,56 | 60 k USD |
| 2026-02-11 | Cochran Christopher P. | Director | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-11 | DeSilva Tara | Director | Buy | 6 k | 10,56 | 60 k USD |
| 2026-02-11 | DeSilva Tara | Director | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-11 | Yerace Daniel Alexander | VP Operations | Buy | 10 k | 10,41 | 104 k USD |
| 2026-02-11 | Yerace Daniel Alexander | VP Operations | Buy | 20 k | 0,00 | 0 USD |
| 2026-02-11 | Mehalick David | CEO and President | Buy | 149 k | 7,05 | 1.0 mn USD |
| 2026-02-11 | Mehalick David | CEO and President | Buy | 51 k | 0,00 | 0 USD |
| 2026-02-11 | Calise Chris | Director | Buy | 6 k | 10,56 | 60 k USD |
| 2026-02-11 | Calise Chris | Director | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-11 | Deschamps Philippe | Director | Buy | 6 k | 10,56 | 60 k USD |
| 2026-02-11 | Deschamps Philippe | Director | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-11 | Cogley Brian | Chief Financial Officer | Buy | 10 k | 10,56 | 106 k USD |
| 2026-02-11 | Cogley Brian | Chief Financial Officer | Buy | 13 k | 0,00 | 0 USD |
| 2026-02-11 | Cogley Brian | Chief Financial Officer | Buy | 10 k | 10,56 | 106 k USD |
| 2026-02-11 | Cogley Brian | Chief Financial Officer | Buy | 13 k | 0,00 | 0 USD |
| 2026-02-11 | DeSilva Tara | Director | Buy | 6 k | 10,56 | 60 k USD |
| 2026-02-11 | DeSilva Tara | Director | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-11 | Deschamps Philippe | Director | Buy | 6 k | 10,56 | 60 k USD |
| 2026-02-11 | Deschamps Philippe | Director | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-11 | Mehalick David | CEO and President | Buy | 149 k | 7,05 | 1.0 mn USD |
| 2026-02-11 | Mehalick David | CEO and President | Buy | 51 k | 0,00 | 0 USD |
| 2026-02-11 | Salkind Gene | Director | Buy | 6 k | 10,56 | 60 k USD |
| 2026-02-11 | Salkind Gene | Director | Buy | 3 k | 0,00 | 0 USD |
| 2026-02-11 | Sheehy Christine Elise | VP Compliance and Secy | Buy | 1 k | 10,56 | 11 k USD |
| 2026-02-11 | Sheehy Christine Elise | VP Compliance and Secy | Buy | 13 k | 0,00 | 0 USD |
| 2026-02-11 | Yerace Daniel Alexander | VP Operations | Buy | 10 k | 10,41 | 104 k USD |
| 2026-02-11 | Yerace Daniel Alexander | VP Operations | Buy | 20 k | 0,00 | 0 USD |
| 2024-01-12 | DeSilva Tara | Director | Buy | 466 | 0,56 | 261 USD |
| 2024-01-12 | DeSilva Tara | Director | Buy | 2 k | 0,58 | 1 k USD |
| 2024-01-12 | DeSilva Tara | Director | Buy | 466 | 0,56 | 261 USD |
| 2024-01-12 | DeSilva Tara | Director | Buy | 2 k | 0,58 | 1 k USD |
| 2024-01-10 | Cogley Brian | Chief Financial Officer | Buy | 5 k | 0,67 | 3 k USD |
| 2024-01-10 | Cogley Brian | Chief Financial Officer | Buy | 5 k | 0,67 | 3 k USD |
| 2024-01-08 | Mehalick David | CEO and President | Buy | 6 k | 0,67 | 4 k USD |
| 2024-01-08 | Mehalick David | CEO and President | Buy | 14 k | 0,66 | 9 k USD |
| 2024-01-08 | Mehalick David | CEO and President | Buy | 6 k | 0,67 | 4 k USD |
| 2024-01-08 | Mehalick David | CEO and President | Buy | 14 k | 0,66 | 9 k USD |
| 2024-01-05 | Cochran Christopher P. | Director | Buy | 7 k | 0,77 | 5 k USD |
| 2024-01-05 | Cochran Christopher P. | Director | Buy | 7 k | 0,77 | 5 k USD |
| 2024-01-05 | Mehalick David | CEO and President | Buy | 5 k | 0,69 | 3 k USD |
| 2024-01-05 | Salkind Gene | Director | Buy | 12 k | 0,69 | 8 k USD |
| 2024-01-05 | Yerace Daniel Alexander | VP of Operations | Buy | 11 k | 0,69 | 7 k USD |
| 2024-01-05 | Mehalick David | CEO and President | Buy | 5 k | 0,69 | 3 k USD |
| 2024-01-05 | Salkind Gene | Director | Buy | 12 k | 0,69 | 8 k USD |
| 2024-01-05 | Yerace Daniel Alexander | VP of Operations | Buy | 11 k | 0,69 | 7 k USD |
| 2023-12-07 | Mehalick David | CEO and President | Sell | 700 k | 0,00 | 0 USD |
| 2023-12-07 | Mehalick David | CEO and President | Sell | 700 k | 0,00 | 0 USD |
| 2023-08-29 | Salkind Gene | Director | Buy | 4 k | 1,01 | 4 k USD |
| 2023-08-29 | Salkind Gene | Director | Buy | 4 k | 1,01 | 4 k USD |
| 2023-08-25 | Salkind Gene | Director | Buy | 29 k | 0,91 | 26 k USD |
| 2023-08-25 | Salkind Gene | Director | Buy | 29 k | 0,91 | 26 k USD |
| 2023-08-23 | Calise Chris | Director | Buy | 9 k | 0,94 | 8 k USD |
| 2023-08-23 | Calise Chris | Director | Buy | 3 k | 0,94 | 2 k USD |
| 2023-08-23 | Calise Chris | Director | Buy | 9 k | 0,94 | 8 k USD |
| 2023-08-23 | Calise Chris | Director | Buy | 3 k | 0,94 | 2 k USD |